Stay updated on Oral PHA-022121 Dose-ranging Clinical Trial
Sign up to get notified when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.

Latest updates to the Oral PHA-022121 Dose-ranging Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page's revision label updated from v3.6.4 to v3.6.5, indicating a new version of the page. This change is limited to metadata and does not modify substantive content or functionality.SummaryDifference0.1%

- Check18 days agoChange DetectedThe latest version shows the submission was returned on 2026-07-28 and is under Quality Control Review, with the study history updated to include key sections such as Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, and Study/Recruitment Status.SummaryDifference0.9%

- Check25 days agoChange DetectedThe study record history adds a new revision tag v3.6.4 and removes the previous v3.6.3, reflecting a newer update to the record.SummaryDifference0.1%

- Check47 days agoChange DetectedThe study history now shows a new version (v3.6.3) with Results Submitted, indicating that results for the trial have been submitted. The previous No Results Posted state and revision v3.6.2 are superseded by this update.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated to v3.6.2, indicating an updated build of the ClinicalTrials.gov interface. This change reflects a backend/UI deployment rather than any new or removed study data on the page.SummaryDifference0.1%

- Check68 days agoChange DetectedThe study is no longer looking for participants, indicating recruitment has closed. The record version has been updated to v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.3%

Stay in the know with updates to Oral PHA-022121 Dose-ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.